Clark Estates Inc’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Sell
845,000
-43,880
-5% -$591K 2.84% 12
2025
Q4
$9.98M Buy
888,880
+105,000
+13% +$1.2M 2.42% 11
2025
Q3
$9.06M Buy
783,880
+290,000
+59% +$3.4M 2.07% 14
2025
Q2
$6.05M Hold
493,880
1.36% 15
2025
Q1
$7.08M Buy
+493,880
New +$7.71M 1.5% 14

Other funds holding AVNS

Clark Estates Inc's AVNS Position: Q1 2026 in Review

Clark Estates Inc reduced its Avanos Medical (AVNS) stake by 4.9% in Q1 2026, selling an estimated $591K and leaving 845,000 shares worth $11.8M. The position accounts for 2.84% of the portfolio, ranked #12.

Clark Estates Inc first reported a position in AVNS in Q1 2025 and has held it in 5 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Clark Estates Inc held 845,000 shares of Avanos Medical worth $11.8M as of Q1 2026.
  • Clark Estates Inc sold 43,880 Avanos Medical shares in Q1 2026, an estimated $591K.
  • Avanos Medical made up 2.84% of Clark Estates Inc's portfolio in Q1 2026, its #12 holding.
  • Clark Estates Inc first reported a position in Avanos Medical in Q1 2025 and has held it in 5 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Clark Estates Inc's 13F filing for Q1 2026, filed 11 May 2026.